2021-07-20 | Purchase | TScan Therapeutics, Inc. TCRX | 10 percent owner | | $15.00 | $2M | -54.29% | |
2018-10-16 | Sale | Salarius Pharmaceuticals, Inc. SLRX | 10 percent owner | | $0.92 | $2.94M | -41.74% | |
2016-11-08 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $7.31 | $51,170 | -44.04% | |
2016-11-07 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $5.70 | $50,559 | -38% | |
2016-06-23 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.28 | $30,456 | -52.52% | |
2016-06-22 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.03 | $31,987 | -50.96% | |
2016-06-21 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.07 | $30,996 | -51.61% | |
2016-06-20 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.37 | $34,110 | -51.2% | |
2016-06-17 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $10.98 | $32,940 | -50.09% | |
2016-06-16 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.10 | $32,190 | -51.16% | |
2016-06-15 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.24 | $32,596 | -50.94% | |
2016-06-14 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.19 | $33,570 | -49.64% | |
2016-06-13 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.90 | $34,510 | -52.51% | |
2016-06-10 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $11.83 | $35,490 | -51.79% | |
2016-06-09 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $12.04 | $36,120 | -52.47% | |
2016-06-08 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $12.24 | $35,496 | -53.44% | |
2016-06-07 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $12.26 | $36,780 | -53.88% | |
2016-06-06 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $12.33 | $36,990 | -53.19% | |
2016-06-03 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $12.79 | $38,370 | -54.34% | |
2016-06-02 | Purchase | Salarius Pharmaceuticals, Inc. SLRX | President and CEO | | $13.22 | $66,100 | -55.56% | |